Experimental Treatments for Long Covid: Peptides, Methylene Blue & What the Evidence Shows

Many people with Long Covid are exploring peptides, methylene blue and other experimental treatments. This evidence-based guide explains the science behind these therapies, what research currently shows, the potential risks, and why medical supervision is essential.

Hospital Acquired COVID in England: What the Data Shows, What Changed, and Why the Numbers Remain Unclear

Hospital acquired Covid became one of the most contested data stories of the pandemic. This is what the numbers actually showed and why they were so hard to count.

Functional Capacity in Long Covid: Why Diagnosis Alone Is Not Enough

Traditional healthcare relies heavily on diagnosis, which can inadequately assess chronic conditions like Long Covid. Many individuals face functional impairments despite clear diagnostic indicators. Emphasizing functional capacity offers a more accurate measure of impact, suggesting necessary reforms in policy and systems to accommodate fluctuating patient needs and improve support for those affected.

How People in Asia Search for COVID and Long COVID: What Internet Data Reveals

Online search patterns reveal public concerns about COVID-19 and Long COVID across Asia, with notable variations in behavior by country and platform. In Japan, interest spikes during infection peaks, while in China, analysis is complicated by platform restrictions. These trends provide valuable insights for public health awareness and clinical research.

Long Covid Symptoms and Concerns: What Google Search Data Reveals

Living with Long COVID involves unpredictable symptoms and slow recovery, leading many to use Google as a vital resource. Analysis of search trends reveals persistent concerns about fatigue, cognitive issues, and mental health, particularly among women. This data highlights significant gaps in healthcare support and calls for better resources and awareness for patient needs.

Why the UK Is Moving On from COVID While Long COVID Still Affects Millions

In the UK, COVID is perceived as a past issue, but Long COVID continues to impact millions, affecting health and employment. Despite persistent symptoms, media narratives avoid linking economic inactivity and health issues back to the pandemic. Structural gaps in healthcare and societal avoidance hinder recognition and support, exacerbating the crisis.

Measuring Long Covid Nationally: Why Are So Many People Missing?

Millions suffer from long COVID, yet most countries lack reliable measurement systems to quantify its impact. Challenges include varying definitions, absence of diagnostic tests, fragmented health records, insufficient public health capacity, and temporary tracking systems. Addressing these issues through standardized definitions, unified health data, and sustained investment is crucial for effective monitoring and care.

Long Covid and Work in the UK: Why People Are Leaving the Workforce

How is Long COVID affecting work in the UK? Explore new 2026 research on employment, lost earnings, workplace adjustments and why many people struggle to remain in work.

The Reality of Long COVID in Aging Populations

The article discusses the misperception surrounding Long COVID in older adults, who are often dismissed due to pre-existing health issues. It highlights the severe impact of Long COVID symptoms, which can significantly disrupt daily life and wellbeing. A call for a paradigm shift in recognizing Long COVID as a serious condition for all ages underscores the need for integrated healthcare and awareness campaigns.

Understanding the Link Between Infections and Aging

Recent research indicates that ageing involves more than just time; persistent infections can accelerate this process. Infections may cause cellular damage, chronic inflammation, and impair immune responses, leading to age-related diseases. Understanding these links could improve treatment and prevention strategies, ultimately enhancing both lifespan and health quality.

What Google Searches Reveal About Long Covid: Insights from Search Data

In the context of Long COVID, Google searches serve as a vital resource for patients seeking understanding amid medical ambiguity. Trend analysis shows sustained interest in symptoms like brain fog and fatigue, especially among women, highlighting gaps in healthcare and the need for tailored support. These searches reflect personal struggles and an urgent call for better medical awareness and resources.

Long COVID: Communities Changing the Healthcare Narrative

Recent years have seen a paradigm shift in healthcare dynamics, especially for conditions like Long COVID. Social media empowers patients to organize, advocate, and lead research efforts, fostering peer support and amplifying their voices. This democratization of knowledge influences research agendas, policy discussions, and challenges traditional medical narratives, creating a collaborative future in medicine.

Decoding ME/CFS: Key Genetic Findings Explained

Recent genetic research has confirmed that Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a biological condition, not merely psychological. The DecodeME study identified eight genetic signals linked to the immune and nervous systems, validating patient experiences. Understanding this can aid healthcare discussions, allowing for better management and support for those affected.

COVID-19, Insurance and the Hidden Cost of Illness in Entertainment and Sport

COVID-19 has largely disappeared from entertainment and sports headlines, but the financial consequences of illness have not. Drawing on UK insurance records, industry agreements and medical research, this article explores the hidden impact of COVID-19 on performers, athletes, freelancers and their careers.

Global Experts Finally Agree on Long COVID. So Why Are Patients Still Struggling?

A global consensus among 179 experts defines Long COVID as a complex condition affecting over 400 million people. It impacts various body systems, often without clear diagnostic tools. The study emphasizes the need for improved medical education, specific guidelines, research into its societal effects, and validation of patient experiences.

Long COVID Disability: Why Rising Sickness Is Not a Mystery

Media outlets mistakenly characterize the rising rates of long-term sickness and disability as a “mystery,” ignoring clear links to COVID-19 and Long COVID. This oversight reflects a broader societal failure to address post-pandemic health challenges, while advocacy for awareness, research, and necessary workplace accommodations is sorely needed.

Can Monoclonal Antibodies Help Long COVID? What the Latest Research Really Shows

Can monoclonal antibodies help Long COVID? Learn how these targeted medicines work, why researchers are studying Sipavibart, Pemgarda and Evusheld, and what current evidence says about viral persistence, NHS access and future treatments.

Role of Galectin-3 in Long COVID Symptoms

Galectin-3 is an inflammatory protein being investigated as a possible contributor to Long COVID. Learn how it may interact with microclots, inflammation and immune dysfunction, and why researchers see it as a promising but still experimental treatment target.